3Ryas, Chang Y, kim DI, et al, r-Glutamy hansfenase as a predictor of: Chronic kidney disease in nonbypertcnsive, and nondiabetic. Korean men Clin chem,2007 ,53 :71-77.
4Lee DH. Blomhoff R,Jaeobs DR Jr. Is serum gammag lutamy ltransfer-ase amarker of oxidative stress? Free Radic Res,2004,38:535- 539.
5Kazami-shirazi L, Endler G winkers et al. Gammaglutamy ltransfer ase and long-term survival : is it just the liver. Clin Chem,2007,53 : 940 -946.
2Peter BL, Carolin M, Alice S, et al. Point- of-care testing (POCT): Current techni- ques and future perspectives[J]. Trends in Analytical Chemistry,2011,30(6): 887-898.
3EP9-A2. Method comparison and bias es- timation using patient samples: approved guideline-2nd edition[S]. CLSI, 2002.
4叶应妩,王毓三,申子瑜.全国临床检验操作规范[M]-3版.南京:东南大学出版社,2006:59.
5Document POCT 09-A. Selection criteria for point-of care testing devices; approved guideline[S]. CLSI, 2010.
6Chand P,Singh R,Singh B,et al. Preoperative ultrasonography as a predictor of difficult laparoscopic cholecystectomy that requires conversion to open procedure[J]. Niger J Surg,2015,21 (2) : 102-105.
7Moghadamrad S,Montani M,Weimann R,et al. Cholestasis in a patient with gallstones and a normal gamma-glutamyl transferase [J]. Hepatology,2013,57(6) :2539-2541.
8Thapa PB, Maharjan DK,Suwal B, et al. Serum gamma glutamyl transferase and alkaline phosphatase in acute cholecystitis[J]. J Nepal Health Res Counc, 2010, 8 (2) : 78-81.
